Renal Cancer
Patient-Reported Outcomes in KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma.
August 18, 2023
Diabetes, Obesity, and Pathologic Upstaging in Renal Cell Carcinoma: Results from a large multi-institutional consortium.
August 17, 2023
A genetic basis for cancer sex differences revealed in Xp11 translocation renal cell carcinoma.
August 15, 2023